GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanjivani Paranterals Ltd (BOM:531569) » Definitions » Gross-Profit-to-Asset %

Sanjivani Paranterals (BOM:531569) Gross-Profit-to-Asset % : 59.10% (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Sanjivani Paranterals Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sanjivani Paranterals's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₹296.8 Mil. Sanjivani Paranterals's average Total Assets over the quarter that ended in Dec. 2024 was ₹502.2 Mil. Therefore, Sanjivani Paranterals's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 59.10%.


Sanjivani Paranterals Gross-Profit-to-Asset % Historical Data

The historical data trend for Sanjivani Paranterals's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanjivani Paranterals Gross-Profit-to-Asset % Chart

Sanjivani Paranterals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.43 46.21 80.57 68.30 64.86

Sanjivani Paranterals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.88 26.50 56.92 57.59 59.10

Competitive Comparison of Sanjivani Paranterals's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Sanjivani Paranterals's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanjivani Paranterals's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanjivani Paranterals's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sanjivani Paranterals's Gross-Profit-to-Asset % falls into.


;
;

Sanjivani Paranterals Gross-Profit-to-Asset % Calculation

Sanjivani Paranterals's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=208.878/( (210.083+434.053)/ 2 )
=208.878/322.068
=64.86 %

Sanjivani Paranterals's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=296.796/( (502.187+0)/ 1 )
=296.796/502.187
=59.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sanjivani Paranterals Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sanjivani Paranterals's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanjivani Paranterals Business Description

Traded in Other Exchanges
N/A
Address
Asha Nagar Park Road, 1202, B-Wing, O2 Business Commercial Park, Mulund (West), Mumbai, MH, IND, 400080
Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The company's main product range includes oral solids and small-volume parenteral and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.

Sanjivani Paranterals Headlines

No Headlines